VIVOZON
LIVE

Serial Number

90505170

Owner

VIVOZON HOLDINGS, INC.

Attorney

Miriam D. Trudell

Filing Date

Feb 2, 2021

Add to watchlist:

No watchlists yet
View on USPTO

VIVOZON Trademark

Serial Number: 90505170 • Registration: 6994147

VIVOZON is a trademark filed by VIVOZON HOLDINGS, INC. on February 2, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

VIVOZON HOLDINGS, INC. (4 trademarks)

(BOJEONG-DONG, JANGEUN MEDICAL PLAZA)
GYEONGGI-DO , KR

Entity Type: 03

Vivozon, Inc. (7 trademarks)

(Cheongdeok-dong, Yongin Techno-Valley)
Yongin-si, Gyeonggi-do , KR

Entity Type: 03

Trademark Details

Filing Date

February 2, 2021

Registration Date

March 7, 2023

Published for Opposition

December 20, 2022

Goods & Services

Pharmaceutical preparations for immunity adjustment; vaccines; vitamin preparations; preparations of trace elements being nutritional supplements for human and animal use; dietary supplements; dietetic food supplements; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases, pain, inflammation and skin disorders; ferments for pharmaceutical purposes; chemico-pharmaceutical preparations, namely, for the treatment of central nervous system diseases, pain, inflammation and skin disorders; chemical preparations for sanitary use; biological preparations for medical purposes, namely, for the treatment of central nervous system diseases, pain, inflammation and skin disorders; chemical preparations for medical or veterinary purposes, namely, for the treatment of central nervous system diseases, pain, inflammation and skin disorders; bacteriological preparations for medical and veterinary use; biotechnological preparations for medical purposes, namely, analgesic preparations, anti-inflammatory preparations, antipyretic preparations, and anti-itch ointment; biochemical preparations for medical purposes for the treatment of central nervous system diseases, pain, inflammation and skin disorders; sanitary preparations for medical use; medicines for human purposes for the treatment of central nervous system diseases, pain, inflammation and skin disorders; veterinary preparations for the treatment of central nervous system diseases, pain, inflammation and skin disorders; nutraceutical preparations for therapeutic or medical purposes for the treatment of central nervous system diseases, pain, inflammation and skin disorders; nutraceuticals for use as dietary supplements

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 14, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 14, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 14, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 14, 2024 REAP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 25, 2024 ASGN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 7, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 7, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 20, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 20, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 30, 2022 NONP
1(B) BASIS DELETED; NEW BASIS REQUESTED
Nov 17, 2022 ADBS
NOTICE OF ALLOWANCE CANCELLED
Nov 17, 2022 IUCN
ATTORNEY REVIEW COMPLETED
Nov 16, 2022 ATRV
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Oct 24, 2022 ATRQ
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Oct 24, 2022 PCBG
ASSIGNED TO PETITION STAFF
Oct 18, 2022 APET
TEAS PETITION TO AMEND BASIS RECEIVED
Sep 16, 2022 TPAD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 10, 2022 EXRA
SOU EXTENSION 1 GRANTED
May 6, 2022 EX1G
SOU EXTENSION 1 FILED
May 6, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
May 6, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 7, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 12, 2021 NPUB
PUBLISHED FOR OPPOSITION
Oct 12, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 22, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 7, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 7, 2021 XAEC
ASSIGNED TO LIE
Sep 3, 2021 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 3, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 3, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 3, 2021 CNEA
ASSIGNED TO EXAMINER
Aug 23, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 6, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 5, 2021 NWOS
NEW APPLICATION ENTERED
Feb 5, 2021 NWAP